Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene

American Journal of Roentgenology

Volumn 192, Issue 1, 2009, Pages 279-287

  Carlson, Stephanie K ^a   Classic, Kelly L ^a   Hadac, Elizabeth M ^a   Dingli, David ^a   Bender, Claire E ^a   Kemp, Bradley J ^a   Russell, Stephen J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Gene therapy; Measles virus; Micro SPECT CT; Molecular imaging; Pancreatic cancer; Sodium iodide symporter; Viral therapy

Indexed keywords

IODINE 123; SODIUM IODIDE SYMPORTER; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOENGINEERING; CELL VIABILITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MEASLES VIRUS; MICROSCOPY; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PANCREAS CANCER; PRIORITY JOURNAL; REPORTER GENE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL TIME; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; GENE THERAPY; HUMANS; MEASLES VIRUS; MICE; MICE, NUDE; MOLECULAR PROBE TECHNIQUES; PANCREATIC NEOPLASMS; PROTEIN ENGINEERING; SYMPORTERS; TRANSFECTION;

EID: 58149269201     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.1205     Document Type: Article

References (32)

1. Cancer statistics for 2007. American Cancer Society Website. www.cancer.org/docroot/STT/stt_0_2007.asp?sitearea=STT+level=1. Accessed October 28, 2008
2. Alberts S, Gores G, Kim G, et al. Treatment options for hepatobiliary and pancreatic cancer. Mayo Clin Proc 2007; 82:628-637
3. Mulvihill S, Warren R, Venook A, et al. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial. Gene Ther 2001; 8:308-315
4. Kuszyk BS, Corl FM, Franano FN, et al. Tumor transport physiology: implications for imaging and imaging-guided therapy. AJR 2001; 177:747-753
5. Kondo Y, Chung YS, Sawada T, et al. Intratumoral injection of an Adriamycin immunoconjugate against human pancreatic cancer xenografts. Jpn J Cancer Res 1995; 86:1072-1079
6. Peng KW, Ahmann GJ, Pham L, Greipp PR, Cattaneo R, Russell SJ. Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood 2001; 98:2002-2007
7. Peng K-W, TenEyck CJ, Galanis E, Kalli KR, Hartmann LC, Russell SJ. Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res 2002; 62:4656-4662
8. Dingli D, Peng K, Harvey M, et al. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 2004; 103:1641-1646
9. Blechacz B, Splinter P, Greiner S, et al. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma. Hepatology 2006; 44:1465-1477
10. Grote D, Russell S, Cornu T, et al. Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood 2001; 97:3746-3754
11. Hasegawa K, O'Connor M, Federspiel M, Russell S, Peng K. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter. Clin Cancer Res 2006; 12:1868-1875
12. Anderson BD, Nakamura T, Russell SJ, Peng K-W. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res 2004; 64:4919-4926
13. Spitzweg C, Harrington KJ, Pinke LA, Vile RG, Morris JC. Clinical review 132: the sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab 2001; 86:3327-3335
14. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996; 379:458-460
15. Dingli D, Diaz R, Bergert E, O'Connor MK, Morris JC, Russell S. Genetically targeted radiotherapy for multiple myeloma. Blood 2003; 102:489-496
16. Spitzweg C, Dietz AB, O'Connor MK, et al. In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther 2001; 8:1524-1531
17. Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CYF, Morris JC. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res 2000; 60:6526-6530
18. Groot-Wassink T, Aboagye EO, Glaser M, Lemoine NR, Vassaux G. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther 2002; 13:1723-1735
19. Marsee DK, Shen DH, MacDonald LR, et al. Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography. Cancer Gene Ther 2004; 11:121-127
20. Dingli D, Kemp BJ, O'Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol 2006; 8:16-23
21. Carlson S, Classic K, Hadac E, et al. In vivo quantitation of intratumoral radioisotope uptake using micro-single photon emission computed tomography/computed tomography. Mol Imaging Biol 2006; 8:324-332
22. Nemunaitis J, Ganly I, Khuri F, et al. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. Cancer Res 2000; 60: 6359-6366
23. Swisher SG, Roth JA, Nemunaitis J, et al. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst 1999; 91:763-771
24. Hadac EM, Peng K-W, Nakamura T, Russell SJ. Reengineering paramyxovirus tropism. Virology 2004; 329:217-225
25. Peng KW, Hadac EM, Anderson BD, et al. Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model. Cancer Gene Ther 2006; 13:732-738
26. Dingli D, Cascino MD, Josić K, Russell SJ, Bajzer Z. Mathematical modeling of cancer radiovirotherapy. Math Biosci 2006; 199:55-78
27. Dingli D, Russell SJ, Morris JC 3rd. In vivo imaging and tumor therapy with the sodium iodide symporter. J Cell Biochem 2003; 90:1079-1086
28. Chen L, Altmann A, Mier W, et al. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene. J Nucl Med 2006; 47:854-862
29. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter. Clin Cancer Res 2005; 11:1483-1489
30. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice. Gene Ther 2006; 13:60-66
31. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors. Hum Gene Ther 2006; 17: 661-668
32. Shimura H, Haraguchi K, Miyazaki A, Endo T, Onaya T. Iodide uptake and experimental I-131 therapy in transplanted undifferentiated thyroid cancer cells expressing the Na-/I- symporter gene. Endocrinology 1997; 138:4493-4496